Critical pathways for the management of preeclampsia and severe preeclampsia in institutionalised health care settings

BMC Pregnancy and Childbirth

Volumn 3, Issue , 2003, Pages

  Perez Cuevas, Ricardo ^a   Fraser, William ^b   Reyes, Hortensia ^a   Reinharz, Daniel ^c   Daftari, Ashi ^d   Heinz, Cristina S ^a   Roberts, James M ^d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL PATHWAY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MATERNAL CARE; MATERNAL HYPERTENSION; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PREECLAMPSIA; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SCREENING TEST;

EID: 2642571006     PISSN: 14712393     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-3-6     Document Type: Article

References (41)

1. Sox H, Blatt M, Higgins M and Marton K: Medical Decision Making. Butterworth-Heinemann, Newton MA 1988.
2. Belizan JM, Villar J, Gonzalez L, Campodonico L and Bergel E: Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991, 325:1399-405.
3. Repke JT and Robinson JN: The prevention and management of preeclampsia and eclampsia. Int J Gynecol & Obstet 1998, 61:1-9.
4. Witlin A and Sibai B: Hypertension in pregnancy: Current concepts of preeclampsia. Annu Rev Med 1997, 48:115-127.
5. Roberts J and Section V Editor: The Etiology of Preeclampsia. In Chesley's Hypertensive Disorders in Pregnancy Stamford, CT, Appleton & Lange Second 1999:377-516.
6. Caritis S, Sibai B, Hauth J, Lindheimer M and VanDorsten P et al.: Predictors of preeclampsia in women at high risk. Am J Obstet Gynecol 1998, 179:946-951.
7. Khedun SM, Moodley J, Naicker T and Maharaj B: Drug management of hypertensive disorders of pregnancy. Pharmacol Ther 1997, 74:221-58.
8. Lewis R and Sibai B: Recent advances in the management of preeclampsia. Matern Foetal Med 1997, 6:6-15.
9. Walker JJ: Care of the patient with severe pregnancy induced hypertension. Eur J Obstet & Gynecol and Rep Biology 1996, 65:127-135.
10. Helewa M, Burrows R, Smith J, Williams k, Brain P and Rabkin S: Report on the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997, 157:715-725.
11. Moutquin JM, Garner PR, Burrows RF, Rey E, Helewa ME, Lange IR and Rabkin SW: Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ 1997, 157(7):907-19.
12. Rey E, LeLorier J, Burgess E, Lange I and Leduc L: Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997, 157(9):1245-54.
13. Pearson SD, Goulart-Fisher D and Lee TH: Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med 1995, 123(12):941-948.
14. Garbin BA: Introduction to clinical pathways. J Healthc Qual 1995, 17(6):6-9.
15. Evidence-Based Care Resource Group: Evidence-Based care: 2. Setting Guidelines: How should we manage this problem? CMAJ 1994, 150(9):1417-1423.
16. Brassard M and Ritter D: The Memory Jogger II. GOAL/QPC Methuen MA 1994.
17. Rymer MM, Summers D and Soper P: Development of Clinical Pathways for Stroke Management: An Example from Saint Luke's Hospital, Kansas City. Clin Geriatr Med 1999, 15(4):741-764.
18. Velasco V, Navarrete H, Cardona J and Madrazo M: Mortalidad Materna por Preeclampsia en el Instituto Mexicano del Seguro Social. Rev Med IMSS 1997, 35(6):439-444.
19. Salha O and Walker JJ: Modern management of eclampsia. Postgrad Med J 1999, 75(880):78-82.
20. Velasco V, Navarrete H, Cardona J and Madrazo M: Mortalidad Materna en el Instituto Mexicano del Seguro Social 1987-1996. Rev Med IMSS (Mex) 1997, 35(5):377-383.
21. Coordinación de Salud Reproductiva y Materno Infantil: Norma Técnico-Medica para la prevención y manejo de la preeclampsia eclampsia. Instituto Mexicano del Seguro Social, Mexico 1995.
22. Silagy CA, Weller DP, Lapsley H, Middleton P, Shelby-James T and Fazekas B: The effectiveness of local adaptation of nationally produced clinical practice guidelines. Fam Prac 2002, 19(3):223-230.
23. Langley C, Faulkner A, Watkins Ch, Gray S and Harvey I: Use of guidelines in primary care. Practitioners perspectives 1998, 15:105-111.
24. Perez-Cuevas R, Reyes-Morales H, Trejo y, Perez JA, Oviedo-Mota MA and Flores-Hernández S: Las guías clí nicas: Instrumentos útiles para mejorar el desempeño de los servicios de salud. In Guías de Práctica Clínica para Medicina Familiar Volume . Edited by: Reyes-Morales H, Trejo y Perez JA, Oviedo-Mota MA, Perez-Cuevas R, surFlores-Hernández. Mexico: Instituto Mexicano del Seguro Social; 2004:.
25. Cincotta RB and Brennecke SP: Family history of preeclampsia as a predictor for preeclampsia in primigravidas. Int J Gynecol & Obstet 1998, 60:23-27.
26. Stone J, Lockwood Ch, Berkowitz G, Alvarez M, Lapinski R and Berkowitz R: Risk factors for severe preeclampsia. Obstet Gynecol 1994, 83:357-361.
27. Roberts JM and Redman CWG: Preeclampsia: more than pregnancy-induced hypertension. Lancet 1993, 341:1447-1451.
28. Chien PF, Khan KS and Arnott N: Magnesium sulphate in the treatment of eclampsia and preeclampsia: an overview of the evidence from randomised trials. Br J Obstet Gynaecol 1996, 103(11):1085-1091.
29. Coetzee EJ, Dommisse J and Anthony J: A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe preeclampsia. Br J Obstet Gynaecol 1998, 105:300-303.
30. Sibai BM, Mercer B, Schiff E and Friedman S: Aggressive versus expectant management of severe preeclampsia at 28-32 weeks' gestation: a randomised controlled trial. Am J Obstet Gynecol 1994, 171:818-822.
31. Visser W, Pampus M, Treffers P and Wallenburg H: Perinatal results of homodynamic and conservative temporising treatment in severe preeclampsia. J Obstet & Gynecol and Reproductive Biology 1994, 53:175-181.
32. Schiff E, Friedman S and Sibai B: Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994, 84:626-30.
33. Friedman SA, Schiff E, Lubarsky SL and Sibai SM: Expectant management of severe preeclampsia remote from term. Clin Obstet Gynecol 1999, 42(3):470-488.
34. Ellis BW and Johnson S: The care pathway: a tool to enhance clinical governance. Clin Perform Qual Health Care 1999, 7(3):134-144.
35. Carnet WG: Clinical Practice Guidelines: a tool to improve care. Qual Manag Health Care 1999, 8(1):13-21.
36. Ghosh K, Downs LS, Padilla LA, Murray KP, Twiggs LB, Letourneau CM and Carson LF: The implementation of critical pathways in gynaecologic oncology in a managed care setting: a cost analysis. Gynecol Oncol 2001, 83(2):378-82.
37. Wazeka A, Valacer DJ, Cooper M, Caplan DW and DiMaio M: Impact of a pediatric asthma clinical pathway on hospital cost and length of stay. Pediatr Pulmonol 2001, 32(3):211-6.
38. Simon NV, Heaps KP and Chodroff CH: Improving the processes of care and outcomes in obstetrics/gynecology. Jt Comm J Qual Improv 1997, 23(9):485-97.
39. Choo J: Critical success factors in implementing clinical pathways/case management. Ann Acad Med Singapore 2001, 30(4 Suppl):17-21.
40. Anonymous: Involve nurses and patients to change physician behavior. Clin Resour manag. 2001, 2(9):135-9.
41. Pan American Health Organization: Reported Maternal Mortality Rate Tabulator. 2001 [http://www.paho.org].